← FDA Drug Approvals (Drugs@FDA)

OPFOLDA

NDA · New Drug Application · Sponsor: AMICUS THERAP US · Approved 2023-09-28

Drug application

FDA Application #
NDA215211
Application type
New Drug Application
Brand name
OPFOLDA
Generic name
MIGLUSTAT
Active ingredients
MIGLUSTAT
Dosage form
CAPSULE
Route
ORAL
Marketing status
Prescription
Sponsor
AMICUS THERAP US
Manufacturer
AMICUS THERAPEUTICS US, LLC
First approval
2023-09-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown